GAMMA Investing’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Sell
8,454
-3,276
-28% -$906K 0.07% 232
2026
Q1
$3.46M Buy
11,730
+1,756
+18% +$522K 0.16% 96
2025
Q4
$2.72M Buy
9,974
+1,762
+21% +$479K 0.14% 113
2025
Q3
$2.22M Sell
8,212
-85
-1% -$23.1K 0.12% 138
2025
Q2
$2.29M Buy
8,297
+1,290
+18% +$351K 0.14% 117
2025
Q1
$1.86M Buy
7,007
+1,381
+25% +$341K 0.14% 132
2024
Q4
$1.31M Buy
5,626
+1,495
+36% +$344K 0.11% 159
2024
Q3
$912K Buy
4,131
+881
+27% +$182K 0.09% 204
2024
Q2
$639K Buy
3,250
+841
+35% +$174K 0.09% 218
2024
Q1
$519K Buy
2,409
+704
+41% +$148K 0.11% 183
2023
Q4
$351K Buy
+1,705
New +$364K 0.1% 183

Other funds holding CME

GAMMA Investing's CME Position: Q2 2026 in Review

GAMMA Investing reduced its CME Group (CME) stake by 28% in Q2 2026, selling an estimated $906K and leaving 8,454 shares worth $1.87M. The position accounts for 0.07% of the portfolio, ranked #232.

GAMMA Investing first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.46M in Q1 2026. 382 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • GAMMA Investing held 8,454 shares of CME Group worth $1.87M as of Q2 2026.
  • GAMMA Investing sold 3,276 CME Group shares in Q2 2026, an estimated $906K.
  • CME Group made up 0.07% of GAMMA Investing's portfolio in Q2 2026, its #232 holding.
  • GAMMA Investing first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's CME Group position peaked at $3.46M in Q1 2026.
  • 382 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.